Keyphrases
Toll-like Receptor 7 (TLR7)
100%
Cancer Vaccine
100%
Delivery Platform
100%
Poly(lactic-co-glycolic acid) Nanoparticles
100%
Dendritic Cells
42%
Vaccine Adjuvant
42%
Nanoparticles
28%
Cancer Immunotherapy
28%
Biopolymers
14%
Nucleic Acids
14%
Antibiotics
14%
Intramuscular Injection
14%
Toll-like
14%
Targeted Drug Delivery
14%
Tumor Antigen
14%
In Vivo Efficacy
14%
Nanoparticulate
14%
T Cell Response
14%
Therapeutic Efficacy
14%
Polymeric Nanoparticles
14%
Subcutaneous Injection
14%
Vaccine Delivery
14%
Inducer
14%
Poly(d,l-lactide-co-glycolide)
14%
Route of Administration
14%
Soluble Form
14%
Injection Site
14%
Conventional Vaccine
14%
Microneedles
14%
Drug Carrier
14%
PLGA Nanoparticles
14%
Nanosized Particles
14%
Imidazoquinoline
14%
TLR7 Agonist
14%
Submicron-sized
14%
Lymphatic Drainage
14%
Cell Uptake
14%
Vaccine Administration
14%
Cocrystal
14%
Adjuvanticity
14%
Drug Delivery Technology
14%
Biocompatible Nanoparticles
14%
Pharmacology, Toxicology and Pharmaceutical Science
Nanoparticle
100%
Toll Like Receptor 7
100%
Tumor Vaccine
100%
Vaccine Adjuvant
33%
Malignant Neoplasm
22%
Immunotherapy
22%
Antibiotics
11%
Microparticle
11%
Subcutaneous Route
11%
Side Effect
11%
Cytokine
11%
Nucleic Acid
11%
Targeted Drug Delivery
11%
Peptides and Proteins
11%
Combination Therapy
11%
Subcutaneous Injection
11%
Drug Carrier
11%
Tumor Antigen
11%
Table Salt
11%
Intramuscular Injection
11%